COMMUNIQUÉS West-GlobeNewswire

Bone Therapeutics SA: The preliminary documents for the Extraordinary General Shareholder Meeting on 9 July 2018 have been made available

21/06/2018 - 07:01

Regulated information The preliminary documents for the Extraordinary General Shareholder Meeting on 9 July 2018 have been made available Gosselies, Belgium, 21 June 2018, 7am CEST - BONE THERAPEUTICS (Euronext Brussels [...]

Bone Therapeutics SA : Mise à disposition des documents préparatoires à l'assemblée générale extraordinaire du 9 juillet 2018

21/06/2018 - 07:01

Information réglementée Mise à disposition des documents préparatoires à l'assemblée générale extraordinaire du 9 juillet 2018 Gosselies, Belgique, le 21 juin 2018, 7h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles [...]

Addex Shareholders Approve All Resolutions at Annual General Meeting

21/06/2018 - 07:01

Geneva, Switzerland, 21 June 2018 - Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, announced today that its shareholders approved all the [...]

Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering

21/06/2018 - 03:37

BOSTON, June 20, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic [...]

AVROBIO, Inc. Announces Pricing of Initial Public Offering

21/06/2018 - 02:42

CAMBRIDGE, Mass., June 20, 2018 (GLOBE NEWSWIRE) -- AVROBIO, Inc. (the “Company”), a Phase 2 clinical stage gene therapy company focused on developing potentially curative ex vivo lentiviral-based gene therapies to [...]

Xeris Pharmaceuticals Announces Pricing of Initial Public Offering of Common Stock

21/06/2018 - 00:31

CHICAGO, June 20, 2018 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (NASDAQ:XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and [...]

Two Publications Recognize NovuHealth as a Top Workplace in Minnesota

20/06/2018 - 23:25

The Star Tribune and Minneapolis/St. Paul Business Journal Both Include NovuHealth on Their Lists for 2018 MINNEAPOLIS, June 20, 2018 (GLOBE NEWSWIRE) -- NovuHealth , the healthcare industry’s leading consumer [...]

Oncobiologics Announces Conversion of Majority of Series A Convertible Preferred Stock

20/06/2018 - 22:21

CRANBURY, N.J., June 20, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) (the “Company”) today announced that GMS Tenshi Holdings Pte. Limited (“GMS Tenshi”), the Company’s strategic business partner and [...]

Reata Announces Initiation of a Phase 1 Trial of RTA 1701, a Selective, Oral Allosteric Inhibitor of RORγt

20/06/2018 - 22:18

IRVING, Texas, June 20, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA), a clinical-stage biopharmaceutical company, today announced the initiation of a Phase 1 clinical trial of Reata’s RTA 1701, a [...]

Galapagos increases share capital through warrant exercises

20/06/2018 - 22:02

Mechelen, Belgium; 20 June 2018, 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 102,801 new ordinary [...]

Harvard Bioscience Subsidiary Data Sciences International Launches Two Telemetry Implants For Measuring Continuous Blood Glucose

20/06/2018 - 22:01

PhysioTel™ Digital M0G and M1G: Designed to Improve Animal Welfare in Large Animal Models ST. PAUL, Minn. and HOLLISTON, Mass., June 20, 2018 (GLOBE NEWSWIRE) -- Data Sciences International (DSI), a subsidiary of [...]

MannKind to Host Institutional Investor and Analyst Meeting

20/06/2018 - 22:01

Renowned Endocrinology Expert Presenting Current Trends in Treatment and Management of Diabetes MannKind’s Chief Medical Officer Presenting New Afrezza ® Data Released at American Diabetes Association’s 78 th Scientific [...]

Oral semaglutide shows statistically significantly greater reductions in HbA1c and weight compared to Victoza® and sitagliptin in the PIONEER 4 and 7 trials

20/06/2018 - 21:22

Bagsværd, Denmark, 20 June 2018 - Novo Nordisk today announced the successful completion and headline results of the phase 3a trials PIONEER 4 comparing oral semaglutide as a treatment for adults with type 2 diabetes to [...]

RavenQuest BioMed Comments on Historic Senate Vote Passing Canada's Cannabis Act

20/06/2018 - 21:02

VANCOUVER, British Columbia, June 20, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE:RQB) (OTCQB:RVVQF) (Franfurt:1IT) (the “ Company ” or “ RavenQuest ”) comments on the historic vote in Canada's upper chamber on [...]

ContraVir Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements

20/06/2018 - 18:30

EDISON, N.J., June 20, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]

Novacap to expand its pharmaceutical offering in the U.S. with the acquisition of PCI Synthesis

20/06/2018 - 18:03

LYON, France and NEWBURYPORT, Mass., June 20, 2018 (GLOBE NEWSWIRE) -- Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has signed an agreement to acquire Boston- [...]

Bio-on inaugurates in Italy the first special bioplastics production plant. 100% natural and biodegradable

20/06/2018 - 18:01

20 million Euro investment behind new production hub, the first owned by Bio-on. Highly sustainable project converted from a former factory: occupies no new land and is powered by electric energy generated by an [...]

Bio-on inaugure, en Italie, son premier établissement de production de bioplastiques spéciaux, naturels et entièrement (100%) biodégradables

20/06/2018 - 18:01

Les investissements dans ce nouvel établissement de production, le premier de propriété Bio-on, se chiffrent à 20 millions d'euros. Il s'agit d'un projet hautement durable, issu de la conversion d'une ancienne usine, [...]

Is pot bad for your heart? Truth is… we don’t know yet

20/06/2018 - 17:32

OTTAWA, June 20, 2018 (GLOBE NEWSWIRE) -- As the Canadian Senate officially passes Bill C-45 on Marijuana legalization, the University of Ottawa Heart Institute (UOHI) has looked at the effects of marijuana on the heart [...]